Glytec

Glytec, The only provider of insulin management software across the full continuum of care, from hospital to home, is a healthcare-focused startup established in 2006. The company is headquartered in the United States and has recently secured a $9.00M Debt Financing investment from Silicon Valley Bank in April 2021. Glytec's FDA-cleared titration software and proprietary algorithms offer personalized diabetes treatment recommendations from hospital to home. The company's team, comprising doctors, nurses, and technologists, is committed to enhancing patient outcomes and mitigating costs for a diverse population requiring insulin treatment, including individuals with or without a diabetes diagnosis. Glytec's innovative approach and focus on improving the quality and cost of care positions it as a notable player within the Health Care industry. For more information, interested parties can follow Glytec on X (@Glytec) or visit www.GlytecSystems.com.